Close

Press Releases

Top results for Vetter in University of St. Gallen benchmarking

Vetter, a global leading contract development and manufacturing organization (CDMO), successfully participated in a lab benchmarking with its incoming goods lab in the past year. The University of St. Gallen (HSG) participated in the project as a scientific partner....

MasterControl Launches Insights for Its EMEA Customers

MasterControl Inc., a leading global provider of software solutions that enable life sciences and other regulated companies to deliver life-changing products to more people sooner, announced the release and general availability of MasterControl Insights to its EMEA customers. MasterControl Insights...

TraceLink Announces Multiple Achievements in the Development of Opus, the Operating Platform for Industry 4.0

TraceLink Inc, the leading digital network platform company, made a series of announcements today that highlight the progress being made in the development of Opus, the operating platform for Industry 4.0. These announcements include the launch of new software...

SkyCell launches next gen 1500X pharma container

SkyCell updates its container lineup with the 1500X Hybrid container with 270 hours independent runtime for temperature-sensitive pharma product transportation New container raises the bar for protecting pharma shipments at +2ยฐC to +8ยฐC or +15ยฐC to +25ยฐC and comes fully...

Lonza Expands the Functionality of Cocoon Platform by Implementing Magnetic Cell Selection

Lonza, a leading global cell and gene therapy manufacturer, announced a functionality expansion of its Cocoonยฎ Platform for automated cell therapy manufacturing. The new Magnetic Selection adds capabilities in cell binding, cell separation, and bead removal (if required), all...

Tonix Pharmaceuticals Announces IND Clearance for TNX-102 SL as a Potential Treatment for Long COVID Syndrome, Also Known as Post-Acute Sequelae of COVID-19

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, announced the U.S. FDA has cleared the Investigational New Drug (IND) application to support a Phase 2 clinical trial with TNX-102 SL1 as a potential treatment for a subset of patients...

World Health Organization Updated Emergency Use Listing Recommends Johnson & Johnson COVID-19 Vaccine for Booster Use

The World Health Organization (WHO) has issued an updated Emergency Use Listing (EUL) for the Johnson & Johnson COVID-19 vaccine, recommending the vaccine for use in boosted regimens in persons aged 18 years and older. The updated EUL recommends...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป